Wolverine Trading’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,100
Closed -$295K 6659
2020
Q4
$295K Buy
+4,100
New +$215K ﹤0.01% 3763
2020
Q3
Sell
-12,900
Closed -$573K 5507
2020
Q2
$573K Buy
+12,900
New +$578K ﹤0.01% 2593
2020
Q1
Sell
-27,200
Closed -$1.26M 5723
2019
Q4
$1.26M Sell
27,200
-6,100
-18% -$264K ﹤0.01% 2197
2019
Q3
$1.35M Buy
33,300
+4,000
+14% +$173K ﹤0.01% 1733
2019
Q2
$1.41M Sell
29,300
-22,800
-44% -$1.2M ﹤0.01% 1768
2019
Q1
$3.26M Buy
+52,100
New +$3.58M 0.01% 1155
2018
Q3
Sell
-54,300
Closed -$1.69M 6522
2018
Q2
$1.69M Hold
54,300
﹤0.01% 1750
2018
Q1
$1.69M Buy
+54,300
New +$1.79M ﹤0.01% 1750
2017
Q4
Sell
-41,500
Closed -$1.37M 5976
2017
Q3
$1.37M Buy
+41,500
New +$1.44M 0.01% 1625
2016
Q4
Sell
-15,200
Closed -$281K 5738
2016
Q3
$281K Buy
+15,200
New +$287K ﹤0.01% 3332

Other funds holding BEAT

Wolverine Trading's BEAT Position: Q1 2021 in Review

Wolverine Trading sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 9,095 shares — an estimated $655K sold.

Wolverine Trading first reported a position in BEAT in Q1 2018 and held it in 7 quarters. The position peaked at $926K in Q4 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Wolverine Trading reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Wolverine Trading sold 9,095 BioTelemetry, Inc. shares in Q1 2021, an estimated $655K.
  • Wolverine Trading first reported a position in BioTelemetry, Inc. in Q1 2018 and held it in 7 quarters.
  • Wolverine Trading's BioTelemetry, Inc. position peaked at $926K in Q4 2019.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Wolverine Trading's 13F filing for Q1 2021, filed 14 May 2021.